HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tony Mok Selected Research

Chronic Disease (Chronic Diseases)

1/2019Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tony Mok Research Topics

Disease

82Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 08/2005
45Neoplasms (Cancer)
01/2024 - 01/2005
24Lung Neoplasms (Lung Cancer)
04/2024 - 08/2004
23Disease Progression
01/2024 - 10/2010
10Diarrhea
12/2023 - 01/2011
10Brain Neoplasms (Brain Tumor)
05/2023 - 01/2016
8Adenocarcinoma of Lung
06/2023 - 08/2005
7Neoplasm Metastasis (Metastasis)
12/2023 - 01/2005
7Exanthema (Rash)
06/2023 - 11/2008
7Adenocarcinoma
12/2018 - 05/2007
6Dyspnea (Shortness of Breath)
12/2023 - 06/2013
6Nausea
12/2023 - 09/2013
6Fatigue
06/2023 - 06/2013
5Vomiting
12/2023 - 12/2014
5Cough
06/2023 - 09/2013
5Acne Vulgaris
06/2023 - 11/2008
5Stomatitis
06/2023 - 09/2013
4Pain (Aches)
12/2023 - 09/2013
3Edema (Dropsy)
05/2023 - 12/2014
3Peripheral Nervous System Diseases (PNS Diseases)
12/2022 - 11/2020
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021 - 06/2011
3Vision Disorders (Hemeralopia)
07/2018 - 06/2013
2Hyperlipidemias (Hyperlipidemia)
03/2024 - 11/2020
2Sleep Initiation and Maintenance Disorders (Insomnia)
12/2023 - 12/2022
2Constipation
12/2023 - 12/2022
2Colorectal Neoplasms (Colorectal Cancer)
12/2018 - 01/2005
2Neutropenia
02/2015 - 11/2008
2Hepatocellular Carcinoma (Hepatoma)
02/2014 - 06/2012
2Alopecia (Baldness)
06/2013 - 11/2008
1Hemoptysis
12/2023
1Hypercholesterolemia
05/2023
1Hypertriglyceridemia
05/2023
1Genomic Instability
12/2022
1Weight Gain
12/2021
1Epilepsy (Aura)
01/2020
1Chronic Disease (Chronic Diseases)
01/2019
1Colonic Neoplasms (Colon Cancer)
12/2018

Drug/Important Bio-Agent (IBA)

33ErbB Receptors (EGF Receptor)IBA
01/2024 - 08/2005
25Tyrosine Kinase InhibitorsIBA
03/2024 - 12/2009
21CrizotinibIBA
05/2023 - 05/2013
18Gefitinib (Iressa)FDA Link
06/2019 - 08/2005
16PlatinumIBA
01/2024 - 11/2008
16Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2019 - 05/2007
14Biomarkers (Surrogate Marker)IBA
12/2023 - 06/2008
11Carboplatin (JM8)FDA LinkGeneric
01/2021 - 02/2006
10Pemetrexed (MTA)FDA Link
06/2023 - 09/2013
9AfatinibIBA
06/2023 - 09/2013
8Anaplastic Lymphoma KinaseIBA
03/2024 - 01/2017
8Cisplatin (Platino)FDA LinkGeneric
06/2023 - 07/2013
8alectinibIBA
01/2023 - 01/2017
8Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 02/2006
7Docetaxel (Taxotere)FDA Link
03/2022 - 11/2008
6lorlatinibIBA
03/2024 - 11/2020
6GemcitabineFDA Link
01/2016 - 02/2006
5osimertinibIBA
01/2024 - 01/2018
5B7-H1 AntigenIBA
01/2023 - 12/2018
5DNA (Deoxyribonucleic Acid)IBA
12/2022 - 06/2008
5ceritinibIBA
12/2022 - 01/2016
4Phosphotransferases (Kinase)IBA
04/2024 - 05/2007
4NivolumabIBA
01/2024 - 01/2019
4Circulating Tumor DNAIBA
12/2022 - 12/2017
4dacomitinibIBA
10/2022 - 04/2014
4atezolizumabIBA
01/2022 - 01/2018
3tremelimumabIBA
12/2023 - 01/2023
3durvalumabIBA
12/2023 - 01/2023
3Tumor Biomarkers (Tumor Markers)IBA
01/2023 - 01/2016
3Cell-Free Nucleic AcidsIBA
01/2022 - 01/2012
3Etoposide (VP 16)FDA LinkGeneric
01/2021 - 03/2016
2RNA (Ribonucleic Acid)IBA
04/2024 - 12/2022
2Immune Checkpoint InhibitorsIBA
12/2023 - 01/2022
2brigatinibIBA
12/2022 - 05/2021
2LigandsIBA
01/2018 - 01/2013
2onartuzumabIBA
02/2017 - 11/2012
2Bevacizumab (Avastin)FDA Link
10/2014 - 06/2014
1tyrosine receptor (receptor, tyrosine)IBA
04/2024
1larotrectinibIBA
04/2024
1entrectinibIBA
04/2024
1cyclo(Arg-Pro) (CI 4)IBA
05/2023
1Creatine Kinase (Creatine Phosphokinase)IBA
12/2022
1Triglycerides (Triacylglycerol)IBA
12/2021
1CholesterolIBA
12/2021
1ensartinibIBA
11/2021
1pembrolizumabIBA
01/2021
1Antineoplastic Agents (Antineoplastics)IBA
01/2020
1serum P-component (CIt)IBA
07/2019
1Imatinib Mesylate (Gleevec)FDA Link
01/2019
1Folic Acid (Vitamin M)FDA LinkGeneric
12/2018
1Capecitabine (Xeloda)FDA Link
12/2018
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2018
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2018
1cabozantinibIBA
10/2018

Therapy/Procedure

46Drug Therapy (Chemotherapy)
04/2024 - 08/2005
31Therapeutics
01/2024 - 08/2004
4Precision Medicine
10/2021 - 12/2009
3Immunotherapy
12/2023 - 01/2015
3Radiotherapy
03/2016 - 10/2010
2Aftercare (After-Treatment)
01/2022 - 02/2017
2Chemoradiotherapy
03/2016 - 01/2015
2Neoadjuvant Therapy
02/2006 - 01/2005
1Time-to-Treatment
06/2019